PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease ReportsDiabetes mellitus
MeSH D003920 - diabetes mellitus
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D044882:Glucose metabolism disorders
$
Success rate
D004700:Endocrine system diseases
0 Companies
0 Drugs
Success rate
D003920: 
Diabetes mellitus
D000071698:Latent autoimmune diabetes in adults
0 Companies
0 Drugs
Success rate
D003921:Experimental diabetes mellitus
0 Companies
0 Drugs
Success rate
D003922:Type 1 diabetes mellitus
$
Success rate
D003924:Type 2 diabetes mellitus
D011236:Prediabetic state
0 Companies
0 Drugs
Success rate
D016640:Gestational diabetes
0 Companies
0 Drugs
Success rate
D056731:Donohue syndrome
0 Companies
0 Drugs
Success rate
D048909:Diabetes complications
$
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
AstraZenecaDapagliflozin, Saxagliptin Qtern  2016-07-15 $5 M Y2017 
SanofiInsulin glulisine Apidra  2004-09-27   
Insulin human Insulin Human Winthrop  2007-01-17   
Insulin aspart Insulin aspart Sanofi  2020-06-25   
Insulin lispro Insulin lispro Sanofi  2017-07-19   
Insulin human Insuman  1997-02-21   
Insulin glargine Lantus  2000-06-09   
Insulin glargine Toujeo (previously Optisulin)  2000-06-26   
Insulin aspart Truvelog Mix  2022-04-25   
Merck & CoInsulin glargine Lusduna  2017-01-03   
PfizerInsulin human Exubera  2006-01-24   
Eli LillyInsulin glargine Abasaglar (previously Abasria)  2014-09-09   
Glucagon Baqsimi  2019-12-16 $652.8 M Q2/23-Q3/24 
Insulin lispro Humalog  1996-04-30 $2,071.6 M Q4/23-Q3/24 
Insulin lispro Liprolog  1997-05-07   
Insulin lispro Lyumjev (previously Liumjev)  2020-03-24   
ViatrisInsulin glargine Semglee  2018-03-23   
BaxterInsulin Inpremzia  2022-04-25   
Novo NordiskInsulin Actraphane  2002-10-07   
Insulin human Actrapid  2002-10-07   
Insulin aspart Fiasp  2017-01-09   
Insulin Insulatard  2002-10-07   
Insulin detemir Levemir  2004-06-01   
Insulin Mixtard  2002-10-07   
Insulin Monotard  2002-10-07   
Insulin aspart NovoMix  2000-08-01   
Insulin aspart NovoRapid  1999-09-07   
Semaglutide Ozempic  2018-02-08   
Insulin Protaphane  2002-10-07   
Insulin aspart, Insulin degludec Ryzodeg  2013-01-21   
Insulin degludec Tresiba  2013-01-20   
Insulin Ultratard  2002-10-07   
Insulin Velosulin  2002-10-07   
ZentivaDuloxetine Duloxetine Zentiva  2015-08-20   
AMMTeKGlibenclamide Amglidia  2018-05-24   
1
2
>
Clinical Trials
Historical Success Rate
Phase 1
71%
44/62
Phase 2
55%
55/100
Phase 3
59%
72/123
Approved: 15Overall Success rate: 23%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
AstraZeneca
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use